Cargando…
Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
Interleukin-33 (IL-33) was recently shown to be involved in the inflammatory tumour microenvironment and the progression of colorectal cancer (CRC). We report here that the expression level of sST2, a soluble form of the IL-33 receptor (ST2L), is inversely associated with the malignant growth of CRC...
Autores principales: | Akimoto, Miho, Maruyama, Riruke, Takamaru, Hiroyuki, Ochiya, Takahiro, Takenaga, Keizo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123057/ https://www.ncbi.nlm.nih.gov/pubmed/27882929 http://dx.doi.org/10.1038/ncomms13589 |
Ejemplares similares
-
Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model
por: Takenaga, Keizo, et al.
Publicado: (2020) -
Hypoxia induces downregulation of the tumor-suppressive sST2 in colorectal cancer cells via the HIF–nuclear IL-33–GATA3 pathway
por: Akimoto, Miho, et al.
Publicado: (2023) -
Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis
por: Akimoto, Miho, et al.
Publicado: (2018) -
The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020) -
The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)